Pre-clinical diabetic cardiomyopathy: Prevalence, screening, and outcome

European Journal of Heart Failure

Volumn 12, Issue 9, 2010, Pages 951-957

  Kiencke, Stephanie ^a   Handschin, Rolf ^a   Von Dahlen, Ruth ^a   Muser, Jürgen ^b   Brunner Larocca, Hans Peter ^c   Schumann, Jörg ^a   Felix, Barbara ^d   Berneis, Kaspar ^e   Rickenbacher, Peter ^a,e  

^a Cardiology Division   (Switzerland)

^b University Hospital Basel ^*  (Switzerland)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

^d Kantonsspital Bruderholz   (Switzerland)

^e Kantonsspital Bruderholz   (Switzerland)

Author keywords

Brain natriuretic peptide; Diabetes; Diabetic cardiomyopathy; Left ventricular dysfunction; Left ventricular hypertrophy; Outcome

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; BODY MASS; CARDIOMYOPATHY; DIABETES MELLITUS; DIABETIC CARDIOMYOPATHY; ECHOCARDIOGRAPHY; EVENT FREE SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SCREENING; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE;

DIABETIC CARDIOMYOPATHIES; ECHOCARDIOGRAPHY, DOPPLER; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; IMMUNOASSAY; MALE; MASS SCREENING; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 77955956486     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfq110     Document Type: Article

References (34)

1. Grundy SM, Benjamin IJ, Burke GL, Chait A, Eckel RH, Howard BV, Mitch W, Smith SC, Sowers JR. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 1999;100: 1134-1146.
2. Solang L, Malmberg K, Ryden L. Diabetes and congestive heart failure. Further knowledge needed. Eur Heart J 1999;20:789-795.
3. Boudina S, Abel ED. Diabetic cardiomyopathy revisited. Circulation 2007;115: 3213-3223.
4. Galderisi M, Anderson KM, Wilson PWF, Levy D. Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy: the Framingham Heart Study. Am J Cardiol 1991;68:85-89.
5. Devereux RB, Roman MJ, Paranicas M, O'Grady MJ, Lee ET, Welty TK, Fabsitz RR, Robbins D, Rhoades ER, Howard BV. Impact of diabetes on cardiac structure and function. The strong heart study. Circulation 2000;101:2271-2276.
6. Luchner A, Burnett JC, Jougasaki M, Hense H, Heid IM, Muders F, Riegger GAJ, Schunklert H. Evaluation of brain natriuretic peptide as marker of left ventricular dysfunction and hypertrophy in the population. J Hypertens 2000;18:1121-1128.
7. Vasan RS, Benjamin EJ, Larson MG, Leip EP, Wang TJ, Wilson PWF, Levy D. Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study. JAMA 2002;288: 1252-1259.
8. Redfield MM, Rodeheffer RJ, Jacobsen SJ, Mahoney DW, Bailey KR, Burnett JC. Plasma brain natriuretic peptide to detect preclinical ventricular systolic or dias-tolic dysfunction. A community-based study. Circulation 2004;109:3176-3181.
9. Palmieri V, Tracy RP, Roman MJ, Liu JE, Best LG, Bella JN, Robbins DC, Howard BV, Devereux RB. Relation of left ventricular hypertrophy to inflammation and albuminuria in adults with type 2 diabetes: the Strong Heart Study. Diabetes Care 2003;26:2764-2769.
10. Vasan RS, Sullivan LM, Roubenoff R, Dinarello CA, Harris T, Benjamin EJ, Sawyer DB, Levy D, Wilson PWF, D'Agostino RB. Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction. The Framingham Heart Study. Circulation 2003;107:1486-1491.
11. Marantz PR, Tobin JN, Wassertheil S, Steingart RM, Wexler JP, Budner N, Lense L, Wachspress J. The relationship between left ventricular systolic function and congestive heart failure diagnosed by clinical criteria. Circulation 1988;77: 607-612.
12. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation 1977;55:613-618.
13. European Study Group on Diastolic Heart Failure. How to diagnose diastolic heart failure. Eur Heart J 1998;19:990-1003.
14. Redfield MM, Jacobsen SJ, Burnett JC, Mahoney DW, Bailey KR, Rodehoffer RJ. Burden of systolic and diastolic ventricular dysfunction in the community. Appreciating the scope of the heart failure epidemic. JAMA 2003;289:194-202.
15. European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003;21:1011-1053.
16. Russo C, Jin Z, Homma S, Rundek T, Elkind MSV, Sacco RL, Di Tullio MR. Effect of diabetes and hypertension on left ventricular diastolic function in a high-risk population without evidence of heart disease. Eur J Heart Fail 2010;12:454-461.
17. Takenaka K, Sakamoto T, Amano K, Oku J, Fujinami K, Murakami T, Toda I, Kawakubo K, Sugimoto T. Left ventricular filling determined by Doppler echocar-diography in diabetes mellitus. Am J Cardiol 1988;61:1140-1143.
18. Robillon JF, Sadoul JL, Jullien D, Morand P, Freychet P. Abnormalities suggestive of cardiomyopathy in patients with type 2 diabetes of relatively short duration. Diabetes Metab 1994;20:473-480.
19. Nicolino A, Longobardi G, Furgi G, Rossi M, Zoccolillo N, Ferrara N, Rengo F. Left ventricular diastolic filling in diabetes mellitus with and without hypertension. Am J Hypertens 1995;8:382-389.
20. Di Bonito P, Cuomo S, Moio N, Sibilio G, Sabatini D, Quattrin S, Capaldo B. Dias-tolic dysfunction in patients with non-insulin-dependent diabetes of short duration. Diabet Med 1996;13:321-324.
21. Zabalgoitia M, Ismaeil MF, Anderson L, Maklady FA. Prevalence of diastolic dysfunction in normotensive, asymptomatic patients with well-controlled type 2 diabetes mellitus. Am J Cardiol 2001;87:320-323.
22. Boyer JK, Thanigaraj S, Schechtman KB, Perez JE. Prevalence of ventricular dias-tolic dysfunction in asymptomatic, normotensive patients with diabetes mellitus. Am J Cardiol 2004;93:870-875.
23. Dawson A, Morris AD, Struthers AD. The epidemiology of left ventricular hypertrophy in type 2 diabetes mellitus. Diabetologia 2005;48:1971-1979.
24. Wachter R, Lüers C, Kleta S, Griebel K, Herrman-Lingen C, Binder L, Janicke N, Wetzel D, Kochen MM, Pieske B. Impact of diabetes on left ventricular diastolic function in patients with arterial hypertension. Eur J Heart Fail 2007;9:469-476.
25. Abhayaratna WP, Marwick TH, Smith WT, Becker NG. Characteristics of left ventricular diastolic dysfunction in the community: an echocardiographic survey. Heart 2006;92:1259-1264.
26. Levy D, Anderson KM, Savage DD, Kannel WB, Christiansen JC, Castelli WP. Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. The Framingham Heart Study. Ann Intern Med 1988;108:7-13.
27. Hammond IW, Devereux RB, Alderman MH, Lutas EM, Spitzer MC, Crowley JS, Laragh JH. The prevalence and correlates of echocardiographic left ventricular hypertrophy among employed patients with uncomplicated hypertension. J Am Coll Cardiol 1986;7:639-650.
28. Savage DD, Drayer JI, Henry WL, Matthews EC, Ware JH, Gardin JM, Cohen ER, Epstein SE, Laragh JH. Echocardiographic assessment of cardiac anatomy and function in hypertensive subjects. Circulation 1979;59:623-632.
29. Lee M, Gardin JM, Lynch JC, Smith VE, Tracy RP, Savage PJ, Szklo M, Ward BJ. Diabetes mellitus and echocardiographic left ventricular function in free-living elderly men and women: the Cardiovascular Health Study. Am Heart J 1997; 133:36-43.
30. Epshteyn V, Morrison K, Krishnaswamy P, Kazanegra R, Clopton P, Mudaliar S, Edelman S, Henry R, Maisel A. Utility of B-type natriuretic peptide (BNP) as a screen for left ventricular dysfunction in patients with diabetes. Diabetes Care 2003;26:2081-2087.
31. Fang ZY, Schull R, Leano R, Mottram PR, Prins JB, Marwick TH. Screening for heart disease in diabetic subjects. Am Heart J 2005;149:349-354.
32. Valle R, Bagolin E, Canali C, Giovinazzo P, Barro S, Aspromonte N, Carbonieri E, Milani L. The BNP assay does not identify mild left ventricular diastolic dysfunction in asymptomatic diabetic patients. Eur J Echocardiogr 2006;7:40-44.
33. Vakili BA, Okin PM, Devereux RB. Prognostic implications of left ventricular hypertrophy. Am Heart J 2001;141:334-341.
34. Huelsmann M, Neuhold S, Strunk G, Moertl D, Berger R, Prager R, Abrahamian H, Riedl M, Pacher R, Luger A, Clodi M. NT-proBNP has a high negative predictive value to rule-out short-term cardiovascular events in patients with diabetes mellitus. Eur Heart J 2008;29:2259-2264.